Why Is OPKO Health (OPK) Up 10.8% Since Last Earnings Report? Zacks Equity Research - Zacks Investment Research - Thu Dec 5, 10:31AM CST Zacks Equity Research - ZACKS - Thu Dec 5, 10:31AM CST
OPKO Health (OPK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
OPKO Health to Participate in the 31st Annual Piper Jaffray Healthcare Conference GlobeNewswire - Tue Nov 26, 7:00AM CST CMTX - Tue Nov 26, 7:00AM CST
OPKO Health, Inc. (OPK) today announced that Company management will be participating in the 31 Annual Piper Jaffray Healthcare Conference being held December 3-5, 2019 at the Lotte New York Palace in...
Opko Health Set to Possibly Pullback After Yesterday's Rally of 1.56% Comtex SmarTrend(R) - Fri Nov 22, 11:35AM CST CMTX - Fri Nov 22, 11:35AM CST
Opko Health (NASDAQ:OPK) traded in a range yesterday that spanned from a low of $1.61 to a high of $1.64. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $1.63...
Novitas Issues Final Local Coverage Determination for the 4Kscore(R) Test GlobeNewswire - Fri Nov 15, 7:00AM CST CMTX - Fri Nov 15, 7:00AM CST
OPKO Health, Inc. (OPK) today announced that Novitas Solutions, Inc. has issued its final Local Coverage Determination (LCD) for Medicare payments for the 4Kscore(R) test with defined coverage criteria,...
OPKO Health (OPK) Q3 Earnings Miss Estimates, Revenues Beat Zacks Equity Research - Zacks Investment Research - Thu Nov 7, 7:16AM CST Zacks Equity Research - ZACKS - Thu Nov 7, 7:16AM CST
OPKO Health (OPK) third-quarter results benefit from higher Product revenues and RAYALDEE prescription growth.
OPKO Health (OPK) Reports Q3 Loss, Tops Revenue Estimates Zacks Equity Research - Zacks Investment Research - Tue Nov 5, 6:05PM CST Zacks Equity Research - ZACKS - Tue Nov 5, 6:05PM CST
OPKO Health (OPK) delivered earnings and revenue surprises of -22.22% and 1.92%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
OPKO Health: 3Q Earnings Snapshot APAI - Tue Nov 5, 4:53PM CST APAI - Tue Nov 5, 4:53PM CST
MIAMI (AP) _ Opko Health Inc. (OPK) on Tuesday reported a loss of $62 million in its third quarter.
OPKO Health Reports 2019 Third Quarter Business Highlights and Financial Results GlobeNewswire - Tue Nov 5, 3:07PM CST CMTX - Tue Nov 5, 3:07PM CST
OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended September 30, 2019.
BioReference Laboratories and GeneDx to Present at NSGC 2019, Demonstrating Commitment to Genetic Counselors and the Research of Rare Genetic Disorders GlobeNewswire - Mon Nov 4, 7:00AM CST CMTX - Mon Nov 4, 7:00AM CST
BioReference Laboratories, Inc., an OPKO Health Company, along with its genetics and genomics laboratory, GeneDx, and women's health division, GenPath, today announced the presentation of new research...
Earnings Preview: OPKO Health (OPK) Q3 Earnings Expected to Decline Zacks Equity Research - Zacks Investment Research - Fri Nov 1, 9:30AM CDT Zacks Equity Research - ZACKS - Fri Nov 1, 9:30AM CDT
OPKO Health (OPK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OPKO Health to Report Third Quarter 2019 Financial Results on November 5, 2019 GlobeNewswire - Fri Nov 1, 7:00AM CDT CMTX - Fri Nov 1, 7:00AM CDT
OPKO Health, Inc. (NASDAQ: OPK) plans to report its operating and financial results for the three months ended September 30, 2019, as well as provide guidance on expected revenues and operating expenses...
OPKO Health Enters Oversold Territory Zacks Equity Research - Zacks Investment Research - Mon Oct 28, 10:23AM CDT Zacks Equity Research - ZACKS - Mon Oct 28, 10:23AM CDT
OPKO Health has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
OPKO Health, Inc. Announces Pricing of its Offering of Common Stock GlobeNewswire - Thu Oct 24, 5:57PM CDT CMTX - Thu Oct 24, 5:57PM CDT
OPKO Health, Inc. ("OPKO Health" or the "Company") (NASDAQ:OPK) today announced the pricing of an underwritten public offering of 50 million shares of its common stock (the "Shares") at a price of $1.50...
Implied Volatility Surging for OPKO Health (OPK) Stock Options Zacks Equity Research - Zacks Investment Research - Thu Oct 24, 9:38AM CDT Zacks Equity Research - ZACKS - Thu Oct 24, 9:38AM CDT
Investors need to pay close attention to OPKO Health (OPK) stock based on the movements in the options market lately.
Enlivex Announces Appointment of New Chief Executive Officer GlobeNewswire - Thu Oct 24, 6:30AM CDT CMTX - Thu Oct 24, 6:30AM CDT
Enlivex Therapeutics, Ltd., a clinical-stage immunotherapy company, today announced the appointment of Dr. Oren Hershkovitz as Chief Executive Officer, effective November 16, 2019. Dr. Hershkovitz served...
OPKO Health, Inc. Announces Proposed Offering of Common Stock GlobeNewswire - Tue Oct 22, 3:09PM CDT CMTX - Tue Oct 22, 3:09PM CDT
OPKO Health, Inc. ("OPKO Health" or the "Company") (NASDAQ:OPK) today announced that, subject to market and other conditions, it intends to offer and sell up to $100 million of shares of its common stock...
OPKO and Pfizer Announce Positive Phase 3 Top-Line Results for Somatrogon, an Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency GlobeNewswire - Mon Oct 21, 7:00AM CDT CMTX - Mon Oct 21, 7:00AM CDT
-- Results demonstrated potential to reduce current dosing frequency from once-daily to a single weekly injection --
OPK November 8th Options Begin Trading Dividendchannel.com - DVND - Thu Sep 26, 10:30AM CDT Dividendchannel.com - DVND - Thu Sep 26, 10:30AM CDT
Investors in OPKO Health Inc saw new options begin trading today, for the November 8th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the OPK options chain for the...
Central Nervous System (CNS) Biomarkers Market By Current Industry Status,Growth Opportunities, Top Key Players, Target Audience And Forecast To 2022 Garth Media - Fri Sep 20, 11:27AM CDT CMTX - Fri Sep 20, 11:27AM CDT
In this report, the global Central Nervous System (CNS) Biomarkers market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between...
Is the Options Market Predicting a Spike in OPKO Health (OPK) Stock? Zacks Equity Research - Zacks Investment Research - Thu Sep 19, 11:13AM CDT Zacks Equity Research - ZACKS - Thu Sep 19, 11:13AM CDT
Investors need to pay close attention to OPKO Health (OPK) stock based on the movements in the options market lately.
